Beijing Strong Biotechnologies, Inc.

Rachunek Zysków i Strat


Sprawozdania
Statystyki
Dywidendy
Rekomendacje
Modele wyceny
Wskaźniki
Prognozy
Analiza techniczna



Wskaźnik 12 11 10 9 8 7 6 5 4 3 2 1 0 13
Rok finansowy 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Data sprawozdania 2011-12-31 2012-12-31 2013-12-31 2014-12-31 2015-12-31 2016-12-31 2017-12-31 2018-12-31 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Okres FY FY FY FY FY FY FY FY FY FY FY FY FY FY
Przychód (mln) 276 380 445 508 566 667 694 774 841 848 1 599 1 511 1 742 1 659
Przychód Δ r/r 0.0% 37.8% 17.0% 14.3% 11.4% 17.9% 4.0% 11.5% 8.6% 0.9% 88.6% -5.5% 15.3% -4.7%
Marża brutto 60.7% 63.4% 68.2% 71.3% 72.1% 68.5% 72.0% 68.7% 68.8% 61.5% 72.1% 74.6% 74.7% 78.2%
EBIT (mln) 116 161 207 238 282 311 324 347 378 153 536 455 594 624
EBIT Δ r/r 0.0% 38.9% 28.4% 14.8% 18.5% 10.2% 4.1% 7.3% 8.8% -59.5% 250.1% -15.0% 30.4% 5.1%
EBIT (%) 42.1% 42.5% 46.6% 46.8% 49.8% 46.6% 46.6% 44.9% 44.9% 18.0% 33.5% 30.1% 34.1% 37.6%
Koszty finansowe (mln) 0 0 0 0 0 13 2 3 1 8 22 53 47 48
EBITDA (mln) 125 171 226 262 301 322 346 376 418 215 637 605 731 701
EBITDA(%) 45.4% 44.9% 50.7% 51.5% 53.2% 48.3% 49.8% 48.6% 49.7% 25.4% 39.8% 40.0% 42.0% 42.2%
Podatek (mln) 17 24 31 36 42 44 48 49 50 15 67 55 71 90
Zysk Netto (mln) 101 137 181 211 245 272 273 301 332 112 406 389 524 533
Zysk netto Δ r/r 0.0% 35.9% 31.8% 16.6% 16.3% 10.9% 0.6% 10.1% 10.3% -66.1% 261.3% -4.1% 34.6% 1.7%
Zysk netto (%) 36.5% 36.0% 40.6% 41.4% 43.3% 40.7% 39.3% 38.8% 39.4% 13.2% 25.4% 25.8% 30.1% 32.1%
EPS 0.25 0.34 0.45 1.01 0.98 0.55 0.55 0.57 0.66 0.21 0.69 0.66 0.9 0.9053
EPS (rozwodnione) 0.25 0.34 0.45 1.01 0.98 0.54 0.55 0.57 0.66 0.21 0.69 0.66 0.88 0.9
Ilośc akcji (mln) 399 400 399 209 250 494 497 527 502 535 588 589 582 588
Ważona ilośc akcji (mln) 407 400 399 209 250 503 497 527 502 535 588 589 595 592
Waluta CNY CNY CNY CNY CNY CNY CNY CNY CNY CNY CNY CNY CNY CNY